Acer Therapeutics Inc. (ACER) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 29 transactions totaling $11.3M, demonstrating a bullish sentiment with $11.3M in net insider flow. The most recent transaction on Nov 17, 2023 involved a transaction of 71,645 shares valued at $0.
No significant insider buying has been recorded for ACER in the recent period.
No significant insider selling has been recorded for ACER in the recent period.
Based on recent SEC filings, insider sentiment for ACER is bullish with an Insider Alignment Score of 100/100 and a net flow of $11.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Acer Therapeutics Inc. (ACER) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading ACER stock, having executed 29 transactions in the past 90 days. The most active insider is Reshentha Beeby (Executive), who has made 1 transactions totaling $5.0M.
Get notified when executives and directors at ACER file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | E. Davis Jefferson | Executive | Disposition | 71,645 | $N/A | $0 | |
| Nov 17, 2023 | S. Palmin Harry | Executive | Disposition | 125,000 | $N/A | $0 | |
| Nov 17, 2023 | Schelling Chris | Executive | Disposition | 2,712,529 | $N/A | $0 | |
| Nov 17, 2023 | Joseph Donald | Executive | Disposition | 14,285 | $N/A | $0 | |
| Nov 17, 2023 | Michael Dunn John | Executive | Disposition | 27,380 | $N/A | $0 | |
| Nov 17, 2023 | Aselage Steve | Executive | Disposition | 483,741 | $N/A | $0 | |
| Nov 29, 2022 | Aselage Steve | Executive | Purchase | 409,836 | $1.22 | $500.0K | |
| Nov 29, 2022 | Schelling Chris | Executive | Purchase | 819,672 | $1.22 | $1000.0K | Large |
| Dec 10, 2021 | Aselage Steve | Executive | Purchase | 7,984 | $2.04 | $16.3K | |
| Dec 9, 2021 | Aselage Steve | Executive | Purchase | 2,016 | $2.15 | $4.3K | |
| Jul 24, 2020 | Schelling Chris | Executive | Purchase | 142,857 | $3.50 | $500.0K | |
| Jul 24, 2020 | Joseph Donald | Executive | Purchase | 14,285 | $3.50 | $50.0K | |
| Jul 24, 2020 | Michael Dunn John | Executive | Purchase | 21,428 | $3.50 | $75.0K | |
| Jul 24, 2020 | Aselage Steve | Executive | Purchase | 45,000 | $3.50 | $157.5K | |
| Mar 2, 2020 | T. Andrews William | Executive | Payment | 3,142 | $3.28 | $10.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $11.3M | 99.9% |
Payment(F) | 1 | $10.3K | 0.1% |
Disposition(D) | 6 | $0 | 0.0% |
Award(A) | 1 | $0 | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Insiders at Acer Therapeutics Inc. are accumulating shares at an accelerated pace. With 10 insiders making 29 transactions totaling $11.3M in purchases versus $0 in sales, the net buying activity of $11.3M signals strong executive confidence. Reshentha Beeby (Executive) leads the buying activity with $5.0M in transactions across all time.